cbdMD (YCBD) Net Income towards Common Stockholders (2016 - 2025)

cbdMD (YCBD) has 10 years of Net Income towards Common Stockholders data on file, last reported at -$324602.0 in Q4 2025.

• For the quarter ending Q4 2025, Net Income towards Common Stockholders rose 67.06% year-over-year to -$324602.0; the trailing twelve-month figure through Dec 2025 stood at -$3.7 million (up 44.5% YoY), and the FY2025 full-year result was -$4.4 million, up 43.21% from the prior year.
• Net Income towards Common Stockholders grew to -$324602.0 in Q4 2025, from -$679968.0 in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $977007.0 in Q2 2021 to a low of -$32.6 million in Q2 2022.
• A 5-year average of -$6.5 million and a median of -$2.6 million in 2023 frame the typical range for Net Income towards Common Stockholders.
• Across the five-year window, Net Income towards Common Stockholders jumped 110.79% in 2021 and tumbled 3440.27% in 2022, its largest moves.
• Tracing YCBD's Net Income towards Common Stockholders over 5 years: stood at -$20.2 million in 2021, then soared by 75.42% to -$5.0 million in 2022, then soared by 59.71% to -$2.0 million in 2023, then jumped by 50.66% to -$985406.0 in 2024, then jumped by 67.06% to -$324602.0 in 2025.
• Business Quant data shows YCBD's Net Income towards Common Stockholders at -$324602.0 in Q4 2025, -$679968.0 in Q3 2025, and -$1.2 million in Q2 2025.